04 Apr Propeller CEO Named One of Top 40 Healthcare Transformers of 2017
There are problems, there are big problems, and then there is asthma and COPD, currently affecting around 500 million people worldwide. The crux of the problem, as with many chronic conditions, is non-adherence. In a report issued last year, Goldman Sachs estimated that $19 billion in US healthcare costs could be saved every year if the number of serious attacks could be reduced through better adherence.
Enter Van Sickle and Propeller Health. Since its debut seven years ago, the company has become one of the most effective digital-health forces in any therapeutic category. Its inhaler-compatible sensors and digital management tools have revolutionized the respiratory space and spurred partnerships with the pharma A-listers therein. “We are working with the leading pharmaceutical companies to create new experiences of chronic respiratory disease and to make their therapies more accessible, personal, powerful, and convenient,” Van Sickle says in response to emailed questions.
Sorry, the comment form is closed at this time.